Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma
ConditionFractures, Bone
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorArtoss Inc.
About this trial
This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.
Eligibility criteria
Qualifiers
Subjects at least 18 years old at the time of injury
Acute fractures, resulting from blunt or penetrating trauma
In the extremities or pelvis
Requiring surgery
Disqualifiers
Certain fracture locations (these apply to non-unions as well)
Hand - metacarpals, phalanges
Forefoot - metatarsals, phalanges
Skull
Trial design
Treatments tested in this trial
- NanoBone® Bone Graft
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov